Newron initiates Phase II study of sNN0029 in patients with Amyotrophic Lateral Sclerosis

Newron announces results of Phase I study of NW-3509; Phase II study in schizophrenia patients planned for Q2 2015

Newron initiates Phase II study of sNN0031 in patients with Parkinson’s disease

Pagination